Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 14;6(12):2277-2282.
doi: 10.3889/oamjms.2018.486. eCollection 2018 Dec 20.

Association of rs1042522 SNP with Clinicopathologic Factors of Breast Cancer Patients in the Markazi Province of Iran

Ali Arash Anoushirvani  1 , Reza Aghabozorgi  1 , Azam Ahmadi  2 , Mohammad Arjomandzadegan  2 , Maryam Sahraei  2 , Sara Khalili  2 , Taha Fereydouni  2 , Zoha Khademi  2
Affiliations

Association of rs1042522 SNP with Clinicopathologic Factors of Breast Cancer Patients in the Markazi Province of Iran

Ali Arash Anoushirvani et al. Open Access Maced J Med Sci. .

Abstract

Background: The nucleotide changes in different genetic loci increased the incidence risk of breast cancer.

Aim: The aim of present study was to investigate genotype distribution at codon 72 of the TP53 gene (rs1042522) in breast cancer patients to achieve a potential diagnostic marker related to some demographic feathers.

Methods: In our case-control study, blood samples were collected from a total of 34 patients harboured breast cancer. DNA was extracted, and nested-PCR was performed. Products were digested with AccII and subsequently were sequenced. Results were compared with samples characteristics.

Results: The PCR results indicated the correct implementation of extraction and amplification protocol. The genotypic distribution at codon 72 of TP53 in control group was 20%, 62.4% and 16.6% for Arg (wildtype), Arg/Pro (heterozygous) and Pro (homozygous variant) respectively. Also, this distribution in the patient group was 23.52% homozygous, 50% heterozygous, and 26.47% another homozygous variant (Adjusted odds ratio: 1.12 and 95%CI = 0.57 to 2.2, P = 0.03). The absence of Arg at codon 72 of TP53 is relevant with age higher than 40 years and metastasis to other organs.

Conclusion: Polymorphism at codon 72 of TP53 was associated with high-grades of breast cancer risk and different responses to chemotherapy treatment. It is recommended genotype distribution of codon 72 of TP53 before chemotherapy.

Keywords: Breast cancer; Chemotherapy; Nested-PCR; TP53.

PubMed Disclaimer

Figures

Figure 1
Figure 1
View of the TP53 chromosome position and the Ensemble databank of variants and SNPs of the TP53 gene. The codon 72 is shown by the blue arrow
Figure 2
Figure 2
Steps of Nested-PCR steps in this study. The yellow arrow shows the 300 bp amplicon of TP53 gene
Figure 3
Figure 3
A) Agarose gel of digestion reaction. Column 1-4 showed heterozygote samples (Arg/Pro) and column 5 showed a homozygote wildtype (Arg); B) Nucleotide sequences from the sequencing of clinical samples (Chromas and Mega4 software)
Figure 4
Figure 4
A) This chart shows the relationship between amplicons sequences and the characteristics of the used clinical samples; B) GraphPad Prism 7.0 software showed association between the Pro at codon 72 of TP53 gene and the Age > 40, BMI > 22, WHR > 0.8 and negative response to chemotherapy (One-way ANOVA test, P = 0.03)
See this image and copyright information in PMC

References

    1. Yarnold J. Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009. Clinical Oncology. 2009;21(3):159–60. https://doi.org/10.1016/j.clon.2008.12.008 PMid:19167201. - PubMed
    1. Israyelyan AH. The development of molecular diagnostics for breast cancer. 2003
    1. McCafferty MP, Healy NA, Kerin MJ. Breast cancer subtypes and molecular biomarkers. Diagnostic Histopathology. 2009;15(10):485–9. https://doi.org/10.1016/j.mpdhp.2009.07.002.
    1. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavaré S. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome biology. 2007;8(10):R214. https://doi.org/10.1186/gb-2007-8-10-r214 PMid:17922911 PMCid: PMC2246288. - PMC - PubMed
    1. Ahmadi A, Khansarinejad B, Hosseinkhani S, Ghanei M, Mowla SJ. miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer. [Jul 15];Gene. 2017 620:15–22. https://doi.org/10.1016/j.gene.2017.03.032 PMid:28363780. - PubMed

LinkOut - more resources